Intervet
Equine Vaccine
EQUINE RHINOPNEUMONITIS VACCINE
KILLED VIRUS
A combination of inactivated, purified, concentrated, adjuvanted,
tissue culture origin Equine Herpesviruses EHV-1 and EHV-4.
INDICATIONS: For vaccination of healthy horses,
6 months of age or older, as an aid in the control of respiratory disease caused
by Equine Herpesvirus.
DOSE: For primary immunization, aseptically
inject 1 mL intramuscularly and repeat the dose in 4 to 6 weeks. A 1 mL dose
should be administered annually and at any time epidemic conditions exist or are
reported and exposure is imminent.
CAUTIONS: Store at 35° to 45° F (2° to 7° C).
Shake well before using. Use entire contents when first opened (10 doses). Do
not vaccinate within 21 days before slaughter. Local reactions may occur if this
product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid
reactions may occur.
 |
CAUTION: Needle is sharp and may cause injury to
self or animals if not handled properly or disposed of properly. |
 |
ANTIDOTE: Epinephrine.
Gentamicin and thimerosal added as preservatives.
* Adjuvant-Intervet's Proprietary Technology.
FOR USE IN ANIMALS ONLY
Intervet Inc., Millsboro, DE 19966
1-800-441-8272
www.intervetusa.com
U.S. Veterinary License No. 286
|
|
|
Code |
|
|
10 Doses |
Ten 1 mL Syringes with Separate Sterile Needles |
069139 |
06630102 |
|
10 Doses |
10 mL |
069140 |
06631002 |
NAC No.: 11061292
of the Day
